Pittsburgh Life Sciences Greenhouse

Pittsburgh Life Sciences Greenhouse is a private equity and venture capital firm specializing in incubation, seed, start up, early stage, growth, maturity, later stage, and expansion stage investments. The firm also provides bridge financing. It seeks to invest in life sciences and biosciences emerging companies with a focus on biotechnology tools and services, bioinformatics, physical, engineering and life sciences research, bionanotechnology, diagnostics and screenings, medical devices, healthcare information technology, medical robotics, therapeutics,developers of therapeutic treatments and tools and services. The firm prefers to invest in Western Pennsylvania. The firm invests between $0.1 million and $10 million in companies. It seeks to invest in firms that plan on relocating to Pennsylvania. Pittsburgh Life Sciences Greenhouse was founded in 2001 and is based in Pittsburgh, Pennsylvania.
DC

Diana Cugliari

President and CEO Pittsburgh Life Sciences Greenhouse

John Glicksman

VP and General Counsel

DH

Diane Hill

Senior Investment Manager

James Jordan

President and CEO

Koleman E. Karleski

Director

MK

Marissa Kuzirian

Investment Manager

John Manzetti

Executive Chairman, Founder and MD, PLSG Accelerat

DS

Delvina Smith

Director of Development and Community Engagement

Samuel Straface

Venture Partner

Alicia Varughese

Executive Associate

63 past transactions

ThermalTherapeuticSystems

Series A in 2009
ThermalTherapeutic Systems was founded in June, 2006 by a team of highly respected experts in the field of hyperthermic perfusion technology, medical device manufacturing, molecular diagnostics and technology commercialization.

Medrobotics Corporation

Series C in 2011
Medrobotics is a medical robotics company developing and commercializing the Flex Robotic System. It manufactures and markets the Flex Robotic System, the first robotic surgical platform with a steerable and shapeable robotic scope. Its platform offers surgeons the unique ability to navigate complex anatomy through a single, small entry point while operating in hard-to-reach anatomical locations that might otherwise be inaccessible with straight, rigid surgical tools.

InteloMed, Inc.

Pre Seed Round in 2007
InteloMed, Inc. manufactures a medical device, which measures patients' cardiovascular stability. It offers CVInsight Patient Monitoring & Informatics System, which captures a patient’s pulse waveform and processes this signal through proprietary algorithms and is used in hospitals, medical facilities, ambulatory, sub-acute, and sleep studies in the areas of hemodialysis, heart failure, and perio-operative. InteloMed, Inc. was founded in 2005 and is based in Warrendale, Pennsylvania.

Forest Devices, Inc.

Venture Round in 2020
Forest Devices is developing AlphaStroke, the first stroke screening device designed for use by medical personnel in any environment. A non-invasive, AI-powered device that can identify a stroke before a CT or MRI is available, AlphaStroke will improve patient outcomes by decreasing time to treatment and by increasing the overall frequency that stroke treatments are provided. Making stroke decisions smarter.

Clinical Platform

Seed Round in 2019
Clinical Platform creates short form, video based patient and caregiver information for people that have cancer and then connects them to clinical trials. The purpose of our business is to improve the outcomes of cancer patients by providing easily accessible and retain-able information on the diagnosis of, treatments for and living with and any type of cancer. It is a fact that better educated patients have improved outcomes.

Clinical Platform

Seed Round in 2019
Clinical Platform creates short form, video based patient and caregiver information for people that have cancer and then connects them to clinical trials. The purpose of our business is to improve the outcomes of cancer patients by providing easily accessible and retain-able information on the diagnosis of, treatments for and living with and any type of cancer. It is a fact that better educated patients have improved outcomes.

Complexa, Inc.

Funding Round in 2013
Complexa, Inc. is a biopharmaceutical company that engages in the development of medicines to treat severe and life-threatening diseases involving fibrosis and inflammation. It develops a compound, CXA-10, which is an oral nitrated fatty acid compound being advanced for the treatment of focal segmental glomerulosclerosis (FSGS) and pulmonary arterial hypertension (PAH). The company was founded in 2008 and is based in Berwyn, Pennsylvania.

Cernostics, Inc.

Series B in 2013
Cernostics is a life science company developing new molecular diagnostic tests for the fight against cancer. Most current diagnostic approaches offer a limited view of cancer because they fail to evaluate the tumor as a system composed of multiple cell types, not merely tumor cells. Its patent-protected technology platform, TissueCypher, uniquely analyzes whole slide digital images with multiplexed fluorescence, providing greater information and accuracy than traditional subjective tissue diagnostics.

Clinical Platform

Convertible Note in 2017
Clinical Platform creates short form, video based patient and caregiver information for people that have cancer and then connects them to clinical trials. The purpose of our business is to improve the outcomes of cancer patients by providing easily accessible and retain-able information on the diagnosis of, treatments for and living with and any type of cancer. It is a fact that better educated patients have improved outcomes.

Blue Belt Technologies, Inc.

Pre Seed Round in 2006
Blue Belt Technologies is a medical device company that focuses on technology and capabilities of surgical instrumentation. They proprietary technology can improve minimally invasive techniques in orthopedics, providing physicians with consistency and accuracy through a myriad of intelligent hand-held tools. It also enables the development of more advanced solutions to patients’ problems. Blue Belt Technologies was acquired by Smith & Nephew on January 5m 2016. The company was founded in 2003 and is headquartered in Pennsylvania, USA.

Cognition Therapeutics

Series A in 2011
Cognition Therapeutics, Inc. is a clinical stage neuroscience company. It develops drugs to restore normal cellular damage responses in neurodegenerative and neuro-ophthalmic disorders. It offers CT1812, an oral brain-penetrant small molecule drug to restore the damaged cellular processes that drive diseases such as Alzheimer’s disease, dry age-related macular degeneration (dry AMD), geographic atrophy and other conditions. Cognition Therapeutics, Inc. was founded in 2007 and is based in Pittsburgh, Pennsylvania.

RedPath Integrated Pathology

Pre Seed Round in 2006
RedPath Integrated Pathology, LLC operates as a reference laboratory and provides support services for oncology cases. It offers PathFinderTG, a testing platform for resolving diagnoses from the original pathology specimen. The company serves pathologists, clinicians, and patients. RedPath Integrated Pathology, LLC was founded in 2004 and is headquartered in Pittsburgh, Pennsylvania.

Celsense

Pre Seed Round in 2007
Celsense is a privately held biotechnology company offering novel MRI agents that allow scientists and clinicians to monitor the location and quantity of transplanted cells. The company's products have applications in the fields of regenerative medicine, immunotherapy, and the study of inflammation and immune system response. Celsense is currently collaborating with leading pharmaceutical and biotechnology organizations and is developing products suitable for human use.

Saladax Biomedical, Inc.

Series A in 2008
Saladax develops rapid blood tests for point-of-care and for laboratory analyzers for use in psychiatry and oncology. The firm has been supplying laboratories and clinicians worldwide with revolutionary diagnostic solutions for more than 15 years.

STARR Life Sciences

Venture Round in 2006
STARR Life Sciences values its medical research customers and is dedicated to developing quality new products specifically designed for mice, rats and other small animals.

Lipella Pharmaceuticals Inc.

Seed Round in 2006
Lipella Pharmaceuticals Inc., a development-stage biotechnology company, which provides supportive care to cancer survivors who acquire hemorrhagic cystitis. It offers surveillance and imaging of patients with a history of transitional cell carcinoma; LP-10 (liposomal tacrolimus), a clinical development for the treatment of hemorrhagic cystitis; and clinical supplies and research products. The company was incorporated in 2005 and is based in Pittsburgh, Pennsylvania.

Immunetrics, Inc.

Seed Round in 2006
Immunetrics, Inc. develops biological models and novel tools for mechanistic modeling needs. It offers Aegis, a software platform for the model development to model developers; disease specific models; and component model libraries. The company’s modeling software includes a set of tools that make the development of models, virtual populations, and experiments, as well as the analysis of human diseases and syndromes. It also provides mechanistic and statistical modeling, and data analysis consulting services. The company was incorporated in 2003 and is based in Pittsburgh, Pennsylvania.

Neuro Kinetics

Funding Round in 2019
Neuro Kinetics, Inc. provides eye tracking technology and non-invasive neuro-otologic diagnostic testing tools to audiologists, ENT’s, neuro-otologists, neuro-ophthalmologists, and neurologists around the globe.The company also provides maintenance, training, and support services; and accessories.
AppCompTech is a software development company focused on a life sciences application in Radiation Treatment Planning for Cancer Therapy. In 2010 an estimated 1.4 million Americans will be diagnosed with cancer and approximately 65% of those cancer victims will receive some form of radiation therapy.

Celsense

Debt Financing in 2010
Celsense is a privately held biotechnology company offering novel MRI agents that allow scientists and clinicians to monitor the location and quantity of transplanted cells. The company's products have applications in the fields of regenerative medicine, immunotherapy, and the study of inflammation and immune system response. Celsense is currently collaborating with leading pharmaceutical and biotechnology organizations and is developing products suitable for human use.

Cellumen

Venture Round in 2010
Cellumen is the innovator in cellular systems biology (CSB™) solutions providing the most accurate predictions of drug efficacy and safety, thus reducing failure rates and cutting development costs. Cellumen’s CSB solutions are driving Discovery Toxicology by addressing the full complexity of disease and safety. Leading global organizations, such as the Mayo Clinic, Hamamatsu Photonics K.K., the EPA, FDA, NIH and top pharmaceutical companies, partner with Cellumen. Cellumen is a partner company of Safeguard Scientifics.
Carmell Therapeutics Corporation manufactures plasma-based biologically-active plastic medical devices from blood plasma for treating injuries to bone and connective tissue. The company’s products include REPAIR bone putty, a putty form of the plasma-based plastics to fill bone defects; and a surgical scaffold that accelerates the healing of injured tendons and ligaments for soft tissue repair. It focuses on the sports medicine market. The company was founded in 2007 and is based in Pittsburgh, Pennsylvania.

Better Body Image LLC

Seed Round in 2016
Better Body Image, Inc. develops a mobile application that uses proprietary data to create personalized exercise routines based on body type, activity level, and overall goals. It offers Better Body Image, a weight loss, wellness, and fitness app that utilizes technology to show users what their body will look like when they’ve achieved their fitness goals. The company was incorporated in 2013 and is based in Pittsburgh, Pennsylvania.
Carmell Therapeutics Corporation manufactures plasma-based biologically-active plastic medical devices from blood plasma for treating injuries to bone and connective tissue. The company’s products include REPAIR bone putty, a putty form of the plasma-based plastics to fill bone defects; and a surgical scaffold that accelerates the healing of injured tendons and ligaments for soft tissue repair. It focuses on the sports medicine market. The company was founded in 2007 and is based in Pittsburgh, Pennsylvania.

Cognition Therapeutics

Seed Round in 2007
Cognition Therapeutics, Inc. is a clinical stage neuroscience company. It develops drugs to restore normal cellular damage responses in neurodegenerative and neuro-ophthalmic disorders. It offers CT1812, an oral brain-penetrant small molecule drug to restore the damaged cellular processes that drive diseases such as Alzheimer’s disease, dry age-related macular degeneration (dry AMD), geographic atrophy and other conditions. Cognition Therapeutics, Inc. was founded in 2007 and is based in Pittsburgh, Pennsylvania.

Diamyd Medical AB (publ)

Pre Seed Round in 2006
Diamyd Medical develops the diabetes vaccine Diamyd®, an antigen-specific immunotherapy based on the exclusively licensed GAD-molecule. GABA constitutes alongside with the diabetes vaccine a key asset in Diamyd Medical and the Company uses its GABA in-licensed technology to develop a proprietary GABA drug product. Diamyd Medical’s shares are traded on Nasdaq Stockholm First North, ticker DMYD B.

Complexa, Inc.

Series A in 2012
Complexa, Inc. is a biopharmaceutical company that engages in the development of medicines to treat severe and life-threatening diseases involving fibrosis and inflammation. It develops a compound, CXA-10, which is an oral nitrated fatty acid compound being advanced for the treatment of focal segmental glomerulosclerosis (FSGS) and pulmonary arterial hypertension (PAH). The company was founded in 2008 and is based in Berwyn, Pennsylvania.

MedSage Technologies

Pre Seed Round in 2004
medSage Technologies provides software and services which enable providers in the rapidly growing home medical equipment industry.

Saladax Biomedical, Inc.

Series C in 2010
Saladax develops rapid blood tests for point-of-care and for laboratory analyzers for use in psychiatry and oncology. The firm has been supplying laboratories and clinicians worldwide with revolutionary diagnostic solutions for more than 15 years.

Clinical Platform

Convertible Note in 2017
Clinical Platform creates short form, video based patient and caregiver information for people that have cancer and then connects them to clinical trials. The purpose of our business is to improve the outcomes of cancer patients by providing easily accessible and retain-able information on the diagnosis of, treatments for and living with and any type of cancer. It is a fact that better educated patients have improved outcomes.

Forest Devices, Inc.

Convertible Note in 2017
Forest Devices is developing AlphaStroke, the first stroke screening device designed for use by medical personnel in any environment. A non-invasive, AI-powered device that can identify a stroke before a CT or MRI is available, AlphaStroke will improve patient outcomes by decreasing time to treatment and by increasing the overall frequency that stroke treatments are provided. Making stroke decisions smarter.

Cognition Therapeutics

Venture Round in 2012
Cognition Therapeutics, Inc. is a clinical stage neuroscience company. It develops drugs to restore normal cellular damage responses in neurodegenerative and neuro-ophthalmic disorders. It offers CT1812, an oral brain-penetrant small molecule drug to restore the damaged cellular processes that drive diseases such as Alzheimer’s disease, dry age-related macular degeneration (dry AMD), geographic atrophy and other conditions. Cognition Therapeutics, Inc. was founded in 2007 and is based in Pittsburgh, Pennsylvania.

Caliber Infosolutions, Inc.

Seed Round in 2009
Caliber Infosolutions Inc. is Pittsburgh PA based global company, focused on solutions for Quality Management specially in Pharma and other regulated industries. Thier highly successful flagship product CaliberLIMSTM is treated as a great asset by their end users.

Ariel Precision Medicine

Convertible Note in 2017
Ariel Precision Medicine, Inc. operates as an integrated genomics and digital health company that provides precision medicine solutions for the diagnosis, monitoring, and treatment of complex chronic diseases and disorders. It also offers ArielDx, a cloud-based clinical decision support tool that simplifies the diagnosis and treatment of pancreatic disease. The company was incorporated in 2013 and is headquartered in Pittsburgh, Pennsylvania.

Quantum OPS

Pre Seed Round in 2011
QuantumOPS is an orthopedic technology company for today's sophisticated operating suite professionals. Our products combine ingenuity and 21st century technology designed to deliver superior clinical outcome for patients, surgeons, nurses and anesthesiologists everywhere. We involve the user in every step of the design process from conception to completion to deliverable goods. Quantum OPS prides itself on its exceptional agility and responsiveness to market need.

StageMark

Series B in 2007
StageMark develops and markets inflammatory diseases identification and monitoring solutions. The company's product, CB-CAPs, enables user to analyze complement products bound to various blood cell types such as erythrocytes, platelets, reticulocytes, and lymphocytes. StageMark, Inc. was founded in 2004 and is headquartered in Pittsburgh, Pennsylvania.

Medrobotics Corporation

Series A in 2009
Medrobotics is a medical robotics company developing and commercializing the Flex Robotic System. It manufactures and markets the Flex Robotic System, the first robotic surgical platform with a steerable and shapeable robotic scope. Its platform offers surgeons the unique ability to navigate complex anatomy through a single, small entry point while operating in hard-to-reach anatomical locations that might otherwise be inaccessible with straight, rigid surgical tools.

ChemDAQ Inc.

Venture Round in 2007
ChemDAQ, Inc. manufactures gas detection systems for protection of personnel exposed to toxic sterilant gases. The company offers ChemDAQ sterilant gas monitoring system; and ChemDAQ data acquisition module, which provides the means of monitoring, displaying, and documenting the sterilant gas levels. It serves hospitals and various organizations. ChemDAQ, Inc. was founded in 1996 and is based in Pittsburgh, Pennsylvania.
Applied Isotope Technologies, Inc. provides elemental, speciated, and molecular measurement solutions for industrial, medical, and academic communities. Its measurement technologies include direct isotope dilution mass spectrometry (D-IDMS); direct speciated isotope dilution mass spectrometry (D-SIDMS); and EPA Method 6800, and analytical quantification method. The company offers QA certification, training, isotopically labeled products, licensing, and test services. Its projects and applications include environmental toxin detection, biomarkers measuring, fossil fuel testing, food and supplement toxin analysis, neuropeptide quantification, and exposomics. The company was founded in 2003 and is based in Pittsburgh, Pennsylvania.

STARR Life Sciences

Venture Round in 2010
STARR Life Sciences values its medical research customers and is dedicated to developing quality new products specifically designed for mice, rats and other small animals.
Carmell Therapeutics Corporation manufactures plasma-based biologically-active plastic medical devices from blood plasma for treating injuries to bone and connective tissue. The company’s products include REPAIR bone putty, a putty form of the plasma-based plastics to fill bone defects; and a surgical scaffold that accelerates the healing of injured tendons and ligaments for soft tissue repair. It focuses on the sports medicine market. The company was founded in 2007 and is based in Pittsburgh, Pennsylvania.

Quantum OPS

Series A in 2012
QuantumOPS is an orthopedic technology company for today's sophisticated operating suite professionals. Our products combine ingenuity and 21st century technology designed to deliver superior clinical outcome for patients, surgeons, nurses and anesthesiologists everywhere. We involve the user in every step of the design process from conception to completion to deliverable goods. Quantum OPS prides itself on its exceptional agility and responsiveness to market need.

Cognition Therapeutics

Venture Round in 2013
Cognition Therapeutics, Inc. is a clinical stage neuroscience company. It develops drugs to restore normal cellular damage responses in neurodegenerative and neuro-ophthalmic disorders. It offers CT1812, an oral brain-penetrant small molecule drug to restore the damaged cellular processes that drive diseases such as Alzheimer’s disease, dry age-related macular degeneration (dry AMD), geographic atrophy and other conditions. Cognition Therapeutics, Inc. was founded in 2007 and is based in Pittsburgh, Pennsylvania.

ATRP Solutions

Venture Round in 2013
ATRP SOLUTIONS develops and manufactures specialty polymers that meet their needs. It recognizes the polymeric materials for improving the performance of commercial products in the areas of personal care and cosmetics, detergents and surfactants, paints, pigments, coatings, and biocompatible materials. It was founded in 2006 and is headquartered in Pittsburgh, Pennsylvania.

ClearCount Medical Solutions

Debt Financing in 2012
ClearCount Medical Solutions is the only provider of a sponge management system that combines the benefits of counting and detection. Counts can be quickly reconciled and in the event of a non-reconciliation, a missing sponge can be located using the SmartWandâ„¢. ClearCount innovations bring to market a comprehensive sponge reconciliation and detection solution that improves patient safety and operational efficiency.

ALung Technologies

Series B in 2013
ALung Technologies, Inc. develops and manufactures medical devices for treating patients with acute respiratory failure. It offers Hemolung Respiratory Assist System, a dialysis-like alternative/ supplement for mechanical ventilation that removes carbon dioxide and delivers oxygen directly to the blood, allowing the patient’s lungs to rest and heal while avoiding intubation and facilitating protective ventilation. The company was founded in 1997 and is based in Pittsburgh, Pennsylvania.

Rinovum Women's Health

Venture Round in 2010
Rinovum Women's Health, Inc. develops medical devices for women. It offers Stork, a medical device that aids in natural fertility and conception in the privacy of home.
AppCompTech is a software development company focused on a life sciences application in Radiation Treatment Planning for Cancer Therapy. In 2010 an estimated 1.4 million Americans will be diagnosed with cancer and approximately 65% of those cancer victims will receive some form of radiation therapy.
NeuroInterventional Therapeutics, Inc. ("NIT", dba Neurointerventions, Inc.) is a Pittsburgh-based company which designs and manufactures advanced catheter systems used to find, trap, and extract thrombus ("blood clots") in a wide range of cerebral vessels, thereby increasing chances of survival and minimizing disability.

StageMark

Venture Round in 2006
StageMark develops and markets inflammatory diseases identification and monitoring solutions. The company's product, CB-CAPs, enables user to analyze complement products bound to various blood cell types such as erythrocytes, platelets, reticulocytes, and lymphocytes. StageMark, Inc. was founded in 2004 and is headquartered in Pittsburgh, Pennsylvania.

Cernostics, Inc.

Series A in 2010
Cernostics is a life science company developing new molecular diagnostic tests for the fight against cancer. Most current diagnostic approaches offer a limited view of cancer because they fail to evaluate the tumor as a system composed of multiple cell types, not merely tumor cells. Its patent-protected technology platform, TissueCypher, uniquely analyzes whole slide digital images with multiplexed fluorescence, providing greater information and accuracy than traditional subjective tissue diagnostics.

Cognition Therapeutics

Series A in 2009
Cognition Therapeutics, Inc. is a clinical stage neuroscience company. It develops drugs to restore normal cellular damage responses in neurodegenerative and neuro-ophthalmic disorders. It offers CT1812, an oral brain-penetrant small molecule drug to restore the damaged cellular processes that drive diseases such as Alzheimer’s disease, dry age-related macular degeneration (dry AMD), geographic atrophy and other conditions. Cognition Therapeutics, Inc. was founded in 2007 and is based in Pittsburgh, Pennsylvania.
Applied Isotope Technologies, Inc. provides elemental, speciated, and molecular measurement solutions for industrial, medical, and academic communities. Its measurement technologies include direct isotope dilution mass spectrometry (D-IDMS); direct speciated isotope dilution mass spectrometry (D-SIDMS); and EPA Method 6800, and analytical quantification method. The company offers QA certification, training, isotopically labeled products, licensing, and test services. Its projects and applications include environmental toxin detection, biomarkers measuring, fossil fuel testing, food and supplement toxin analysis, neuropeptide quantification, and exposomics. The company was founded in 2003 and is based in Pittsburgh, Pennsylvania.
Carmell Therapeutics Corporation manufactures plasma-based biologically-active plastic medical devices from blood plasma for treating injuries to bone and connective tissue. The company’s products include REPAIR bone putty, a putty form of the plasma-based plastics to fill bone defects; and a surgical scaffold that accelerates the healing of injured tendons and ligaments for soft tissue repair. It focuses on the sports medicine market. The company was founded in 2007 and is based in Pittsburgh, Pennsylvania.

Crystalplex Corporation

Seed Round in 2007
Crystalplex Corporation develops nanocrystals for photoluminescent, electroluminescent, and photovoltaic applications. The Company’s product Sapphire quantum dots provides stable crystal design and flexible polymer matrix morphology. The company was founded in 2001 and is based in Pittsburgh, Pennsylvania.

Medrobotics Corporation

Series G in 2015
Medrobotics is a medical robotics company developing and commercializing the Flex Robotic System. It manufactures and markets the Flex Robotic System, the first robotic surgical platform with a steerable and shapeable robotic scope. Its platform offers surgeons the unique ability to navigate complex anatomy through a single, small entry point while operating in hard-to-reach anatomical locations that might otherwise be inaccessible with straight, rigid surgical tools.

PeriOptimum

Seed Round in 2010
PeriOptimum provides workflow management solutions and consulting services for the healthcare industry. It offers real-time technology and process management solutions that allow hospitals to improve workflow in the operating room environment and also enables doctors, nurses, and managers to access patient location and clinical information. The company’s solution portfolio includes RealView, a real time workflow management system that allows users to see patient status in real-time and in multiple views; PeriOperative Improvement Evaluation, a process evaluation solution for on-site analysis and off-site data extraction and analysis; Surgical Analytics Services, a service to isolate, analyze, benchmark, and improve indicators; and Surgical Capacity Improvement Program, a process improvement program for the perioperative process. It also provides PeriOp Education Services, a program that enables hospitals to train their new recruits on critical topics and orient them on the hospital's perioperative department; PathFinder, an RFID-based tracking, workflow management, and communications system; and data analytics and workflow reengineering services.

Clinical Platform

Funding Round in 2019
Clinical Platform creates short form, video based patient and caregiver information for people that have cancer and then connects them to clinical trials. The purpose of our business is to improve the outcomes of cancer patients by providing easily accessible and retain-able information on the diagnosis of, treatments for and living with and any type of cancer. It is a fact that better educated patients have improved outcomes.

Proteopure

Pre Seed Round in 2006
Proteopure offers protein isolation solutions for proteomic results. The company provides a universal method for isolating proteins. Its sample preparation kit uses a protein capture technology, and can specifically separate out proteins from various contaminants, including salts, nucleic acids, and detergents. Proteopure is headquartered in Pittsburgh, Pennsylvania.
Carmell Therapeutics Corporation manufactures plasma-based biologically-active plastic medical devices from blood plasma for treating injuries to bone and connective tissue. The company’s products include REPAIR bone putty, a putty form of the plasma-based plastics to fill bone defects; and a surgical scaffold that accelerates the healing of injured tendons and ligaments for soft tissue repair. It focuses on the sports medicine market. The company was founded in 2007 and is based in Pittsburgh, Pennsylvania.

ParentPlus

Seed Round in 2007
ParentPlus was formed to alleviate male-factor subfertility by bringing innovative biotechnology to millions of subfertile couples for whom intra-uterine insemination (IUI) might be an appropriate therapy. This therapy, with spousal or donor sperm, is underutilized ― perhaps in part because it is not typically discussed in the popular press.

Lipella Pharmaceuticals Inc.

Seed Round in 2008
Lipella Pharmaceuticals Inc., a development-stage biotechnology company, which provides supportive care to cancer survivors who acquire hemorrhagic cystitis. It offers surveillance and imaging of patients with a history of transitional cell carcinoma; LP-10 (liposomal tacrolimus), a clinical development for the treatment of hemorrhagic cystitis; and clinical supplies and research products. The company was incorporated in 2005 and is based in Pittsburgh, Pennsylvania.